To understand the regulatory role of OLA1 in breast cancer resistance to PTX, MCF-7 resistant cell line to PTX was developed (named as MCF-7-PTR) through continuous induction of MCF-7 with PTX at a low concentration (100 nM). Here, OLA1 is linked to breast carcinoma.